TNT: Raising more questions than answers?

Michael B Jameson^{1

2}, Andrew R L Stevenson³, Samuel Y Ngan^{4

5}

Affiliations

¹ Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand.
² Oncology Department, Waikato District Health Board, Hamilton, New Zealand.
³ Department of Surgery, University of Queensland, Brisbane, Queensland, Australia.
⁴ Division of Radiation Oncology, Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁵ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Editorial

Michael B Jameson et al. Asia Pac J Clin Oncol. 2022 Dec.

. 2022 Dec;18(6):489-492.

doi: 10.1111/ajco.13760. Epub 2022 Mar 24.

Michael B Jameson^{1

2}, Andrew R L Stevenson³, Samuel Y Ngan^{4

5}

¹ Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand.
² Oncology Department, Waikato District Health Board, Hamilton, New Zealand.
³ Department of Surgery, University of Queensland, Brisbane, Queensland, Australia.
⁴ Division of Radiation Oncology, Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁵ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

References

1. Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22-iv40.
1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Rectal Cancer Version 2.2021 - September 10, 2021. National Comprehensive Cancer Network; 2021.
1. Fokas E, Appelt A, Glynne-Jones R, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol. 2021:18;805-816.
1. Feng W, Yu B, Zhang Z, Li J, Wang Y. Current status of total neoadjuvant therapy for locally advanced rectal cancer. Asia Pac J Clin Oncol. 2022:18;544-557.
1. Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29-42.